Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Rectal Neuroendocrine Tumor Clinical Trial

Official title: Cap Endoscopic Mucosal Resection(EMR-C) Versus Endoscopic Submucosal Dissection(ESD) for Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Status Not yet recruiting

Clinical Trial Summary

Cap-assisted endoscopic mucosal resection (EMR-C) and endoscopic submucosal dissection (ESD) have both been reported to be effective treatment methods for small rectal neuroendocrine tumor (NET) in limited studies. Which one is better has not been determined. We aimed to compare the efficacy and safety of EMR-C and ESD for the treatment of small rectal NET.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Neuroendocrine Tumors
• Rectal Neuroendocrine Tumor

• NCT number: NCT03982264
• Study type: Interventional
• Source: Nanfang Hospital of Southern Medical University
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 20, 2019
• Completion date: December 20, 2021